Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Brainstorm Cell Therapuetics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

22 Aug 2015 Reuters Investment Profile 12 $20.00

Thomson Reuters Stock Report - Brainstorm Cell Therapuetics Inc (BCLI-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

28 Aug 2015 Thomson Reuters Stock Report 11 $25.00

BRAINSTORM CELL THERAPEUTICS INC (BCLI) 12-months forecast

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

23 Aug 2015 Pechala's Reports 1 $15.00

ValuEngine Rating and Forecast Report for BCLI

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

22 Aug 2015 ValuEngine, Inc. 11 $25.00

BRAINSTORM CELL THERAPEUTICS INC (BCLI) - REPORT FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

22 Aug 2015 Pechala's Reports 1 $25.00

ValuEngine Industry Report for Medical-Biomed/Genetics(BCLI)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

20 Aug 2015 ValuEngine, Inc. 10 $49.00

BrainStorm Cell Therapeutics Inc.: Stock Price Doesn't Reflect NurOwn's Potential Value in ALS

The following is an excerpt from the Streetwise Reports interview with Eden Rahim, Portfolio Manager and Options Strategist w...

12 Aug 2015 Streetwise Reports 2 $12.00

BrainStorm Cell Therapeutics Inc. (BCLI) - Financial Analysis Review

BrainStorm Cell Therapeutics Inc. (BCLI) - Financial Analysis Review Summary BrainStorm Cell Therapeutics Inc. (BrainStorm) i...

11 Aug 2015 GlobalData 40 $125.00

ValuEngine Industry Report for Medical-biomed/genetics(BCLI)

Advanced academic research that brings you superior investment strategies in an actionable format. Industry Analysis Report, ...

23 Jul 2015 ValuEngine, Inc. 10 $49.00

BrainStorm Cell Therapeutics Inc.: BCLI Reports Good Data from Phase 2a Trial with NurOwn

The following is an excerpt from the Streetwise Reports interview with Jason Napodano, senior biotech analyst at Zacks Invest...

08 Jul 2015 Streetwise Reports 2 $12.00